KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) EBITDA (2016 - 2025)

Historic EBITDA for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to -$246000.0.

  • CareDx's EBITDA rose 9820.71% to -$246000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $59.6 million, marking a year-over-year increase of 13587.33%. This contributed to the annual value of $40.8 million for FY2024, which is 12004.54% up from last year.
  • Per CareDx's latest filing, its EBITDA stood at -$246000.0 for Q3 2025, which was up 9820.71% from -$11.1 million recorded in Q2 2025.
  • CareDx's EBITDA's 5-year high stood at $84.4 million during Q4 2024, with a 5-year trough of -$122.6 million in Q4 2023.
  • Over the past 5 years, CareDx's median EBITDA value was -$15.4 million (recorded in 2021), while the average stood at -$15.5 million.
  • As far as peak fluctuations go, CareDx's EBITDA crashed by 212062.94% in 2022, and later soared by 16880.67% in 2024.
  • Quarter analysis of 5 years shows CareDx's EBITDA stood at -$15.4 million in 2021, then decreased by 24.16% to -$19.1 million in 2022, then crashed by 541.38% to -$122.6 million in 2023, then surged by 168.81% to $84.4 million in 2024, then tumbled by 100.29% to -$246000.0 in 2025.
  • Its last three reported values are -$246000.0 in Q3 2025, -$11.1 million for Q2 2025, and -$13.4 million during Q1 2025.